(Q45837740)

16 December 2017

title

Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis (English)

1 reference

16 December 2017

0 references

0 references

1 reference

systemic inflammation

1 reference

Brian J McHugh

3

0 references

James D Chalmers

1

object named as

James D Chalmers

1 reference

16 December 2017

author name string

Maeve P Smith

2

1 reference

16 December 2017

Cathy Doherty

4

1 reference

16 December 2017

John R Govan

5

1 reference

16 December 2017

Adam T Hill

6

1 reference

16 December 2017

language of work or name

English

0 references

publication date

28 June 2012

1 reference

16 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

16 December 2017

volume

186

1 reference

16 December 2017

issue

7

1 reference

16 December 2017

page(s)

657-665

1 reference

16 December 2017

Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

British Thoracic Society guideline for non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Systemic markers of inflammation in stable bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Mortality in bronchiectasis: a long-term study assessing the factors influencing survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Neutrophil chemotaxis in bronchiectasis: a study of peripheral cells and lung secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Neutrophils in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

Systemic Inflammation and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201203-0487OC

10.1164/RCCM.201203-0487OC

21 January 2018

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017